Mylan Laboratories' Prescription: Fool by Numbers

Recs

0

On Nov. 1, Mylan Laboratories (NYSE: MYL) released third-quarter earnings for the period ended Sept. 30.

  • There was robust top-line and earnings growth compared to the year-ago quarter.
  • Mylan's fentanyl transdermal system was the key growth driver, contributing 20% to total revenues.
  • Net profit increased 116.8% to $78 million, capitalizing on double-digit revenue growth and greatly improved margins.
  • EPS growth was aided by a shrinking share count.

(Figures in millions, except per-share data)

Income Statement Highlights

Avg. Est.

Q3 2006

Q3 2005

Change

Sales

$351

$366.7

$298.0

23%

Net Profit*

--

$77.5

$35.8

116.8%

EPS

$0.32

$0.36

$0.16

125%

Diluted Shares

--

215.1

229.3

(6.2%)

*Net profit does not include income from discontinued operations.

Get back to basics with a look at the income statement.

Margin Checkup

Q3 2006

Q3 2005

Change*

Gross Margin

53.48%

48.07%

5.41

Operating Margin

36.70%

19.46%

17.24

Net Margin

21.15%

12.00%

9.15

*Expressed in percentage points.

Margins are the earnings engine. See how they work.

Balance Sheet Highlights

Assets

Q3 2006

Q3 2005

Change

Cash + ST Invest.

$611.7

$631.5

(3.1%)

Accounts Rec.

$252.5

$239.0

5.7%

Inventory

$303.3

$255.4

18.8%



Learn the ways of the balance sheet.

Cash Flow Highlights

A statement of cash flows was not provided.

Find out why Fools always follow the money.

Related Companies:

  • Barr Pharmaceuticals (NYSE: BRL)
  • Teva Pharmaceutical Industries (Nasdaq: TEVA)
  • Watson Pharmaceutical (NYSE: WPI)

Related Foolishness:

Want to weigh in on Mylan or any other pharmaceuticals? Check out CAPS, The Motley Fool's new stock-picking service, and let your voice be heard!

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 516961, ~/Articles/ArticleHandler.aspx, 12/1/2009 6:22:21 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Is Everybody Losing It in Finance's Nervous Breakdown?

Related Tickers

12/22/2008 4:02 PM
BRL $65.80 Down +0.00 +0.00%
Barr Pharmaceutica… CAPS Rating: ****
WPI $37.55 Up +0.46 +1.24%
Watson Pharmaceuti… CAPS Rating: ***
MYL $18.23 Up +0.36 +2.01%
Mylan Laboratories… CAPS Rating: ***
TEVA $53.38 Up +0.59 +1.12%
Teva Pharmaceutica… CAPS Rating: *****

Community: Investing Wiki

Term Of The Hour

Chapter 11: Chapter 11 is a type of bankruptcy as designated by the United States bankruptcy code.

Want to learn more or edit this definition?
Click here to read more!